Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission - Experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL study group (GCLLSG).

Titel:: Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission - Experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL study group (GCLLSG).
Dokumenttyp:: Meeting Abstract
Autor(en):: Wendtner, CM; Ritgen, M; Schweighofer, CD; Fingerle-Rowson, G; Campe, H; Jaeger, G; Eichhorst, B; Busch, R; Diem, H; Engert, A; Stilgenbauer, S; Doehner, H; Kneba, M; Emmerich, B; Hallek, M
Zeitschriftentitel:: Blood
Jahr:: 2003
Band / Volume:: 102
Heft / Issue:: 11
Seitenangaben Beitrag:: 676A-676A
Sprache:: eng
Print-ISSN:: 0006-4971
TUM Einrichtung:: Institut für Medizinische Statistik und Epidemiologie
BibTeX

Vorkommen: